Commenting on the news that the European Union has rejected the UK's request to re-open negotiations on the Northern Ireland Protocol agreed post Brexit, Layla McCay, director of policy and international relations at the NHS Confederation, said:
“It’s unacceptable and very concerning that patients in Northern Ireland could find themselves without essential medication next year unless the UK and EU can find a solution to the problems being caused by the malfunctioning of the Protocol.
“The EU’s rebuttal of UK proposals to make changes to the Protocol means that after 31st December this year, the agreed ‘grace period’ allowing medicines from the rest of the UK to be imported to Northern Ireland without having to satisfy EU rules will run out.
“New treatments approved by the UK’s medicines regulator, the MHRA, won’t be legally available in Northern Ireland unless approved by the EU’s medicines regulator, the EMA.
"Patients and healthcare providers in Northern Ireland must not become collateral damage in the UK and EU’s political shellfire. The NHS Confederation and Brexit Health Alliance have been calling urgently for patients to be taken out of the firing line, this news raises the stakes even higher”.
InFocus - our policy and international work
Dr Layla McCay, NHS Confederation's Policy Director, will give an overview of the current policy priorities for the NHS Confederation and our members.
26 October 2021 11:00 - 12:00 GMT
NHS Confed Conference - a round up of day one
See what happened on day one of NHS Confed Conference, our three-day virtual event bringing together 5,000 leaders across health and social care.
15 June 2021
What leaving the EU means for health and social care in Wales
Frequently asked questions on what leaving the EU means for the sector in Wales.
22 January 2021